FBLG
FibroBiologics, Inc.
1.10$
-2.6%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +16.1% | +5.4% | +2.2% | +2.1% | +7.0% | +5.2% | +28.0% | +12.1% | +1.3% | +1.3% | -32.1% | – | |
| – | -1.1% | +21.5% | +10.1% | -1.2% | -4.7% | +1.3% | +32.3% | -3.4% | -0.3% | -1.1% | +1.9% | – | |
| – | -36.9% | +31.8% | +10.5% | -109.5% | – | – | – | – | -2,403.4% | – | – | – | |
| – | -99.5% | +300.0% | +725.0% | -83.3% | +800.0% | -56.6% | +395.3% | -97.2% | -100.0% | – | – | – | |
| – | -99.5% | +300.0% | +725.0% | -83.3% | +800.0% | -56.6% | +395.3% | -97.2% | – | – | – | – | |
| – | – | – | – | – | – | -100.0% | – | -100.0% | – | – | -149.6% | – | |
| – | -100.0% | – | -105.2% | – | +108.7% | -100.0% | – | -100.0% | – | -70.2% | +459.2% | – | |
| – | – | – | – | – | +232.1% | -186.4% | – | -2,334.8% | – | -12,737.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.